Evidence map›Paper›PMID 37059078›Full record

Trial reportJournal of speech, language, and hearing research : JSLHR2023

Crowdsourced Perceptual Ratings of Voice Quality in People With Parkinson's Disease Before and After Intensive Voice and Articulation Therapies: Secondary Outcome of a Randomized Controlled Trial.

Tara McAllister, Christopher Nightingale, Gemma Moya-Galé, Ava Kawamura, Lorraine Olson Ramig

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of speech, language, and hearing research : JSLHR, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Voice Outcomes of Clear Speech Cueing in Individuals With Parkinson's Disease.Journal of voice : official journal of the Voice Foundation · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Tara McAllisterNew York University, NY.ORCID 0000-0003-2230-2897
Christopher NightingaleGallaudet University, Washington, DC.
Gemma Moya-GaléLong Island University, Brooklyn, NY.ORCID 0000-0003-4933-1110
Ava KawamuraGeorgetown University, Washington, DC.
Lorraine Olson RamigUniversity of Colorado Boulder.
Google (United States) · US

Funding

EFFICACY OF VOICE TREATMENT FOR PARKINSONS DISEASER01DC001150 · NIDCD · UNIVERSITY OF COLORADO AT BOULDER · PI RAMIG, LORRAINE O. · 1990 to 2011
$5.8M
Biofeedback-Enhanced Treatment for Speech Sound Disorder: Randomized Controlled Trial and Delineation of Sensorimotor SubtypesR01DC017476 · NIDCD · NEW YORK UNIVERSITY · PI Tara McAllister · 2019 to 2026
$5.3M
NIDCD NIH HHS R01 DC001150NIDCD NIH HHS R01 DC017476
6 · The paper itself

Abstract

purposeLimited research has examined the suitability of crowdsourced ratings to measure treatment effects in speakers with Parkinson's disease (PD), particularly for constructs such as voice quality. This study obtained measures of reliability and validity for crowdsourced listeners' ratings of voice quality in speech samples from a published study. We also investigated whether aggregated listener ratings would replicate the original study's findings of treatment effects based on the Acoustic Voice Quality Index (AVQI) measure.

methodThis study reports a secondary outcome measure of a randomized controlled trial with speakers with dysarthria associated with PD, including two active comparators (Lee Silverman Voice Treatment [LSVT LOUD] and LSVT ARTIC), an inactive comparator (untreated PD), and a healthy control group. Speech samples from three time points (pretreatment, posttreatment, and 6-month follow-up) were presented in random order for rating as "typical" or "atypical" with respect to voice quality. Untrained listeners were recruited through the Amazon Mechanical Turk crowdsourcing platform until each sample had at least 25 ratings.

resultsIntrarater reliability for tokens presented repeatedly was substantial (Cohen's κ = .65-.70), and interrater agreement significantly exceeded chance level. There was a significant correlation of moderate magnitude between the AVQI and the proportion of listeners classifying a given sample as "typical." Consistent with the original study, we found a significant interaction between group and time point, with the LSVT LOUD group alone showing significantly higher perceptually rated voice quality at posttreatment and follow-up relative to the pretreatment time point.

conclusionsThese results suggest that crowdsourcing can be a valid means to evaluate clinical speech samples, even for less familiar constructs such as voice quality. The findings also replicate the results of the study by Moya-Galé et al. (2022) and support their functional relevance by demonstrating that the effects of treatment measured acoustically in that study are perceptually apparent to everyday listeners.

Indexed as

CrowdsourcingParkinson DiseaseHumansReproducibility of ResultsSpeech AcousticsTreatment OutcomeVoice QualityVoice Training

Identifiers

PMID37059078
PMCPMC10457080
OpenAlexW4365503441

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.